The U.S. Food and Drug Administration said on Friday it has authorized the first diagnostic test for the new coronavirus that allows patients to collect saliva samples at-home.

The decision is part of the FDA’s efforts to expand testing capabilities for the fast-spreading virus, which has caused over 70,000 deaths in the United States.

The saliva test kit was developed by RUCDR Infinite Biologics, a unit of Rutgers’ Human Genetics Institute of New Jersey, and its collaborators, Spectrum Solutions and Accurate Diagnostic Labs.

[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]

The test will cost US$150 and needs to be fully supervised by a practitioner via telemedicine to ensure proper sample collection, a spokeswoman for RUCDR Infinite Biologics’ partner, Vault Health, told Reuters.

2:17Coronavirus outbreak: WHO analyzing wastewater to determine COVID-19 circulation globally

Coronavirus outbreak: WHO analyzing wastewater to determine COVID-19 circulation globally

“With our team of practitioners, we have capacity to manage 10,000 tests per day and are building to scale,” Vault Health CEO Jason Feldman said.

 » READ MORE FROM GLOBAL NEWS